Abstract
A patient with thymic carcinoma underwent Ga-67 scintigraphy, and increased uptake was noted in the anterior mediastinum and bone metastases. After the completion of therapy, Ga-67 scintigraphy showed no radiotracer uptake, although a residual mass was observed on computed tomography (CT). However, a new lesion was seen on Ga-67 imaging in the left lower lung field, corresponding to a suspected metastatic pulmonary nodule that was seen on CT. Before and after treatment, Ga-67 scintigraphy appeared to be superior to CT and was clinically useful in the management of the patient.
| Original language | English |
|---|---|
| Pages (from-to) | 126-128 |
| Number of pages | 3 |
| Journal | Clinical Nuclear Medicine |
| Volume | 29 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2004.02 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Anterior mediastinal tumor
- Ga-67 citrate
- Scintigraphy
- SPECT
- Thymic carcinoma
Quacquarelli Symonds(QS) Subject Topics
- Medicine
Fingerprint
Dive into the research topics of 'Ga-67 Uptake in Thymic Carcinoma: Utility of Ga-67 Scintigraphy in Patient Management'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver